This early experimentation has allowed the company to take a step back and avoid getting swept up in the frantic AI agent ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.

AWS has unveiled a strategic shift to autonomous "Agentic AI" with the Nova Act browser model and 3nm Trainium3 chips, aiming ...

The Trump administration released its much-anticipated National Security Strategy this week. CFR convened six of its experts ...

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial intelligence (AI) in early drug development.

Sickle cell disease is associated with chronic oxidative stress, hemolysis, inflammation, and progressive multi--organ injury, including significant cardiopulmonary complications. Mitochondrial ...

CEO Qiming He details how Newsun’s China-rooted, globally deployed innovation model is redefining biosolutions and ...

An organoid standards working group has been established, bringing together experts from around the world, with Chinese scholars leading the effort to gather international expertise to develop a ...

Strategy's (MSTR) preferred shares fell alongside bitcoin (BTC-USD) this week, pushing up implied yields and likely making future funding for BTC purchases more expensive, according to a media report ...

“MSTR’s entire business model is a fraud,” the Euro Pacific Asset Management global strategist said Sunday on X, challenging Strategy Chair Michael Saylor to a debate at the cryptocurrency conference ...